Everest Medicines Limited (FRA:6HN)
Germany · Delayed Price · Currency is EUR 5.05
-0.05 (-0.98%)
Last updated: Dec 1, 2025, 8:07 AM CET
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of €1.82 billion as of December 1, 2025. Its market cap has increased by 30.26% in one year.
Market Cap
1.82B
Enterprise Value
1.72B
Revenue
101.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.05
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 2.25B to 1.82B, a decrease of -19.12%. That is a compound annual growth rate of -4.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 1.82B | -5.98% |
| Dec 31, 2024 | 1.94B | 150.05% |
| Dec 29, 2023 | 775.42M | 20.25% |
| Dec 30, 2022 | 644.85M | -44.62% |
| Dec 31, 2021 | 1.16B | -44.37% |
| Dec 31, 2020 | 2.09B | -7.13% |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |